SEC Filings TLDR

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, reporting a significant decrease in its ownership of Kestrel Group Ltd's common stock. As of September 30, 2025, BlackRock's ownership has dropped to 254,000 shares, representing 3.3% of the total outstanding shares. This marks a substantial reduction f...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership of 4.4% in Borr Drilling Ltd. The filing indicates that BlackRock now holds 12,647,684 shares, up from 7,313,463 shares previously, representing a 137.14% increase in shares owned. The value of these shares has also risen by 137.14%...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership in Amphastar Pharmaceuticals, Inc. As of September 30, 2025, BlackRock beneficially owns 5,333,463 shares of Amphastar's common stock, representing 11.5% of the total outstanding shares. This marks a significant increas...

BlackRock, Inc. filed a Schedule 13G/A amendment with the SEC, reporting a 4.98% ownership in Bankwell Financial Group, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 392,560 shares of common stock, with sole voting power over 381,382 shares and sole dispositive power over all 392,...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for BANK OF MARIN BANCORP, reporting a decrease in its ownership stake. As of September 30, 2025, BlackRock, Inc. beneficially owns 1,102,191 shares of common stock, representing 6.8% of the total outstanding shares. This marks a decrease of 390,156 shares fr...

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting an increased ownership in Bakkt Holdings, Inc. As of September 30, 2025, BlackRock beneficially owns 734,431 shares of Bakkt's common stock, representing 4.6% of the total outstanding shares. This marks a significant increase from previous holdings, ...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for BXP, Inc., reporting a decrease in its ownership of BXP's common stock. As of September 30, 2025, BlackRock beneficially owns 15,897,016 shares, representing 10.0% of the total outstanding common shares. This marks a decrease of 3,608,302 shares from its ...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its stake in Boston Omaha Corp. As of September 30, 2025, BlackRock owns 1,527,816 shares of Class A Stock, representing 4.9% of the total outstanding shares. This marks a decrease of 131,317 shares from its previous holding, w...

BlackRock, Inc. filed an amendment to its Schedule 13G for BJ's Restaurants, Inc., reporting a decrease in its ownership. As of September 30, 2025, BlackRock beneficially owns 3,107,792 shares, representing 14.0% of the outstanding common stock. This marks a decrease of 135,779 shares from its previous filing. The fili...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for BIO-RAD LABORATORIES, INC., disclosing ownership of 1,618,123 shares of Class A Stock, representing 7.4% of the total outstanding shares. The filing indicates a decrease of 144,536 shares (-8.2%) compared to the previous report, with the value of the hold...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for BGC Group, Inc., reporting a decrease in its ownership. As of September 30, 2025, BlackRock owns 51,743,911 shares of Class A Stock, representing 14.2% of the total outstanding shares. This marks a decrease of 2,265,164 shares (4.19%) from its previous fi...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in Bed Bath & Beyond, Inc. As of September 30, 2025, BlackRock holds 4,123,240 shares of common stock, representing a 7.2% ownership stake. This marks an increase of 302,868 shares from its previous filing, with the value of t...

BlackRock Portfolio Management LLC has filed an amendment to its Schedule 13G for Baxter International Inc, reporting beneficial ownership of 39,204,985 shares of common stock, representing 7.6% of the total outstanding shares. The filing indicates that BlackRock has sole voting power over 38,736,192 shares and sole di...

BlackRock, Inc. has filed a Schedule 13G/A amendment indicating a reduction in its ownership stake in Bar Harbor Bankshares. As of September 30, 2025, BlackRock owns 1,159,246 shares, representing 6.9% of the outstanding common stock. This marks a decrease of 169,470 shares (12.75%) from its previous holdings. The fili...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, reporting a 6.4% ownership in Avidity Biosciences, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 8,631,771 shares of Avidity Biosciences' common stock, with sole voting power over 8,455,367 shares and sole disposit...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Avantor, Inc., reporting a decrease in its beneficial ownership. As of September 30, 2025, BlackRock owns 59,049,575 shares of Avantor's common stock, representing 8.7% of the total outstanding shares. This marks a decrease of 12,855,571 shares from its p...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for ATRICURE INC, reporting ownership of 3,862,837 shares, which represents 7.8% of the company's common stock. The filing indicates that BlackRock has sole voting power over 3,782,723 shares and sole dispositive power over all 3,862,837 shares. The amendment...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Atkore Inc., reporting a decrease in its ownership stake. As of September 30, 2025, BlackRock owns 2,462,609 shares of Atkore Inc.'s common stock, representing a 7.3% ownership stake. This marks a decrease of 211,492 shares from its previous filing, refle...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, reporting a 4.9% ownership in ARRIVENT BIOPHARMA INC. The filing indicates that BlackRock, Inc. beneficially owns 2,007,338 shares of the company's common stock. The shares are held in the ordinary course of business and not for the purpose of influenci...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a reduction in its stake in Archer Aviation Inc. As of September 30, 2025, BlackRock owns 45,379,325 shares of Class A Stock, representing a 7% ownership stake. This marks a decrease of 2,542,339 shares from its previous filing, with the value of th...

BlackRock, Inc. has filed an amendment to its Schedule 13G for Aquestive Therapeutics Inc., reporting ownership of 6,426,343 shares of common stock, representing 5.3% of the total outstanding shares. The filing indicates that BlackRock, Inc. has sole voting power over 6,290,838 shares and sole dispositive power over al...

BlackRock, Inc. filed a Schedule 13G/A amendment on October 17, 2025, reporting a decrease in its ownership of Apple Hospitality REIT, Inc. common stock. BlackRock's ownership decreased by 1,477,965 shares, representing a 3.79% reduction, bringing its total holdings to 37,515,618 shares, or 15.8% of the outstanding com...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its ownership of ANTERIX INC. common stock. As of September 30, 2025, BlackRock owns 950,842 shares, representing a 5.1% ownership stake. This marks a decrease of 189,637 shares (16.63%) from its previous holdings. The filing i...

BlackRock, Inc. filed an amendment to its Schedule 13G for Amphastar Pharmaceuticals, Inc., reporting a decrease in its ownership. As of September 30, 2025, BlackRock owns 5,333,463 shares, representing 11.5% of the common stock. This is a decrease of 335,330 shares from the previous filing, reflecting a 5.9154% reduct...

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting its ownership of 790,456 shares of American Outdoor Brands, Inc., representing 6.2% of the outstanding common stock. This filing reflects a decrease in the value of its holdings by $1,109,131.92, or 15.89%, and an increase in the number of shares hel...